BioSpace News Archive

VERO Biotech Inc., a commercial-stage healthcare business dedicated to neonatal intensive care and the acute care hospital community, announced that it will be honored during Premier, Inc.'s annual supplier Innovation Celebration at the 2023 Breakthroughs Conference and Exhibition.

NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) (“NLS” or the “Company”) today announced positive data from five recently completed in vitro drug-drug interaction studies investigating the potential for DDI of mazindol, a triple monoamine reuptake inhibitor and partial orexin-2 agonist, as well as its hydrolyzed metabolite (M6).

Aspen Neuroscience, Inc. co-founder and Senior Vice President, Research & Development, Andrés Bratt-Leal, PhD, will present “Enabling Autologous iPSC-Derived Cell Therapies with Predictive Genomics,” during the Focus Sessions taking place during this week’s 2023 International Society for Stem Cell Research Annual Meeting in Boston, Mass.

electroCore, Inc., a commercial-stage bioelectronic medicine and wellness company, announced that Company CEO, Dan Goldberger, will present at the Healthcare Virtual Conference Part II, presented by Maxim Group LLC and hosted by M-Vest.

MediWound Ltd. announced its participation in the upcoming Healthcare Virtual Conference Part II, organized by Maxim Group LLC and hosted by M-Vest.

Onconova Therapeutics, Inc. presented preclinical data on narazaciclib at the 17th International Conference on Malignant Lymphoma, which is taking place in Lugano, Switzerland, through June 17, 2023.

Femasys Inc. announced that Kathy Lee-Sepsick, founder, president & chief executive officer, has been invited to present at the Healthcare Virtual Conference Part II, presented by Maxim Group LLC and hosted by M-Vest.

MindRank, a clinical stage artificial intelligence (AI)-empowered drug discovery company, announced today that the first healthy volunteer dosed in the Phase 1 study of their oral small-molecule glucagon-like peptide 1 receptor agonist (GLP-1 RA), MDR-001 for the treatment of obesity and type 2 diabetes mellitus (T2DM).

Complete Genomics, Inc., a pioneering genomics company, unveiled updated mission/vision statement to reflect renewed ambitions in taking on more for a better world, in celebration of its 18th anniversary.

LivaNova PLC, a market-leading medical technology and innovation company, will host a conference call to discuss its second-quarter 2023 results on Wednesday, July 26, 2023 at 1 p.m. London time.